Details of the Drug

General Information of Drug (ID: DM47ELH)

Drug Name
Oncolysin M
Synonyms Anti-CD33-bR; Anti-My9-bR
Indication
Disease Entry ICD 11 Status REF
leukaemia 2A60-2B33 Discontinued in Phase 1 [1]
Cross-matching ID
TTD ID
D0E4EP

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Myeloid cell surface antigen CD33 (CD33) TTJVYO3 CD33_HUMAN Modulator [2]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

Molecular Expression Atlas of This Drug

The Studied Disease leukaemia
ICD Disease Classification 2A60-2B33
Molecule Name Molecule Type Gene Name p-value Fold-Change Z-score
Myeloid cell surface antigen CD33 (CD33) DTT CD33 5.37E-13 0.58 1.13
Molecular Expression Atlas (MEA) Jump to Detail Molecular Expression Atlas of This Drug

References

1 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800003885)
2 US patent application no. 6,926,898, Albumin fusion proteins.